Solesence Q4 revenue flat, full-year up 19%
Overview
US health care solutions provider's Q4 revenue was flat yr/yr, full-year revenue up 19%
Company's Q4 net income turned positive, but full-year net income declined sharply
Company launched Transform & Transcend initiative and expanded patent portfolio in 2025
Outlook
Company expects to deliver on full-year 2026 objectives, citing strong momentum entering the year
Company says Transform & Transcend initiative aims for sustainable, profitable growth above industry averages
Company plans to launch new skin health and healing technology in 2026
Result Drivers
OPERATIONAL INITIATIVES - Co cited the launch of the Transform & Transcend initiative, focused on operational excellence and aligning execution with recent growth, as supporting Q4 momentum
ORGANIZATIONAL CHANGES - Co said organizational changes contributed to strong momentum exiting 2025, per CFO Laura Riffner
NEW BRAND PARTNERS - Co acquired 20 new brand partners in facial skincare and color cosmetics during 2025
Company press release: ID:nGNX8kJGZ3
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| $12.50 mln |
|
Q4 Net Income |
| $163,000 |
|
Q4 Gross Profit |
| $3.43 mln |
|
Q4 Income From Operations |
| $186,000 |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
